We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-0.26%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$102B
AUM Growth
-$731M
(-0.71%)
Cap. Flow
+$803M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
263
New
6
Increased
107
Reduced
91
Closed
3
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
JPMorgan Chase
JPM
|
+$285M |
| 3 |
NetApp
NTAP
|
+$279M |
| 4 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$225M |
| 5 |
HP
HPQ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$585M |
| 2 |
CME Group
CME
|
+$258M |
| 3 |
Honeywell
HON
|
+$194M |
| 4 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$131M |
| 5 |
Intuit
INTU
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.73% |
| 2 | Technology | 26.95% |
| 3 | Industrials | 13.36% |
| 4 | Consumer Discretionary | 8.68% |
| 5 | Miscellaneous | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NUVA
176
DELISTED
NuVasive, Inc.
NUVA
| $42.7M | 0.04% |
901,000
| – | – |
2013 Q2
8 quarters
|
|
177
PepsiCo
PEP
$175B
| $42M | 0.04% |
450,000
| – | – |
2013 Q2
8 quarters
|
|
178
Edwards Lifesciences
EW
$50.8B
| $39.9M | 0.04% |
1,680,000
| – | – |
2013 Q2
8 quarters
|
|
179
Las Vegas Sands
LVS
$24.8B
| $39.4M | 0.04% |
750,000
| – | – |
2013 Q2
8 quarters
|
|
180
Cerus
CERS
$455M
| $38.4M | 0.04% |
7,400,000
+100,000
| +1% | +$474K |
2015 Q1
1 quarter
|
|
|
GUID
181
DELISTED
Guidance Software, Inc.
GUID
| $37.7M | 0.04% |
4,451,707
| – | – |
2013 Q2
8 quarters
|
|
|
SZYM
182
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $37.6M | 0.04% |
11,972,209
+80,500
| +0.7% | +$276K |
2013 Q2
8 quarters
|
|
183
Axcelis
ACLS
$3.55B
| $36.5M | 0.04% |
3,085,500
| – | – |
2014 Q1
5 quarters
|
|
|
VA
184
DELISTED
Virgin America Inc.
VA
| $31.7M | 0.03% |
1,154,900
+1,111,293
| +2,548% | +$32.2M |
2015 Q1
1 quarter
|
|
185
DELISTED
Du Pont De Nemours E I
DD
| $31.1M | 0.03% |
511,653
+3,686
| +0.7% | +$248K |
2013 Q2
8 quarters
|
|
186
Stratasys
SSYS
$624M
| $30.9M | 0.03% |
885,000
+240,000
| +37% | +$10.1M |
2013 Q2
8 quarters
|
|
187
Stryker
SYK
$112B
| $28.2M | 0.03% |
295,500
| – | – |
2013 Q2
8 quarters
|
|
188
Newell Brands
NWL
$2.46B
| $26.2M | 0.03% |
638,060
+375,000
| +143% | +$15M |
2014 Q1
5 quarters
|
|
189
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $26.2M | 0.03% |
500,200
-130,000
| -21% | -$6.74M |
2013 Q2
8 quarters
|
|
|
UTIW
190
DELISTED
UTI WORLDWIDE INC
UTIW
| $25.8M | 0.03% |
2,581,000
+136,000
| +6% | +$1.31M |
2014 Q2
4 quarters
|
|
191
Arbutus Biopharma
ABUS
$850M
| $24.7M | 0.02% |
2,080,000
+1,531,397
| +279% | +$23.3M |
2015 Q1
1 quarter
|
|
192
Constellium
CSTM
$3.45B
| $23.8M | 0.02% |
2,014,500
-17,600
| -0.9% | -$277K |
2014 Q4
2 quarters
|
|
193
Salesforce
CRM
$203B
| $22.1M | 0.02% |
317,460
| – | – |
2013 Q2
8 quarters
|
|
194
DELISTED
CIRCOR International, Inc
CIR
| $22M | 0.02% |
403,500
-8,000
| -2% | -$442K |
2013 Q2
8 quarters
|
|
195
DELISTED
Diebold Nixdorf Incorporated
DBD
| $19.7M | 0.02% |
562,000
| – | – |
2013 Q2
8 quarters
|
|
|
XOOM
196
DELISTED
XOOM CORP COM
XOOM
| $19.6M | 0.02% |
928,800
-611,000
| -40% | -$11.4M |
2014 Q2
4 quarters
|
|
197
NN Inc
NNBR
$327M
| $19.3M | 0.02% |
755,000
+37,800
| +5% | +$994K |
2014 Q1
5 quarters
|
|
198
Mativ Holdings
MATV
$644M
| $19.2M | 0.02% |
481,200
| – | – |
2013 Q2
8 quarters
|
|
199
DELISTED
Mobileye N.V.
MBLY
| $17.6M | 0.02% |
330,650
| – | – |
2014 Q3
3 quarters
|
|
200
DELISTED
Hawaiian Holdings, Inc.
HA
| $17.6M | 0.02% |
740,000
+15,000
| +2% | +$350K |
2014 Q2
4 quarters
|
|
Similar funds
Primecap Management's Q2 2015 Portfolio in Review
As of Q2 2015, Primecap Management held 263 positions worth $102B, down 0.71% from $102B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 3.4%. Primecap Management opened 6 new positions and exited 3, leaving the 263-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q2 2015 buy was Pfenex Inc.: 2,371,388 shares worth $46M.
- Primecap Management added most to Alibaba in Q2 2015, an estimated $347M increase.
- Primecap Management's biggest Q2 2015 reduction was CME Group, cutting an estimated $258M.
- Primecap Management fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $585M.
- Primecap Management's ten largest holdings make up 35% of its $102B portfolio in Q2 2015.
- Primecap Management opened 6 new positions and closed 3 in Q2 2015.
- Primecap Management's portfolio value fell 0.71% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q2 2015, filed 13 Aug 2015.